TETRAPHASE PHARMACEUTICALS INC: cashflow_operating

Value{"amount": -11155000, "concept": "us-gaap:NetCashProvidedByUsedInOperatingActivities", "currency": "USD"}
Period2020-01-01 – 2020-03-31
Statuscurrent
EntityTETRAPHASE PHARMACEUTICALS INC
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001564590-20-022821 · Open the official SEC filing →
Retrieved: 2026-08-19T13:11:20.304535+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001373707/cashflow-operating/2020-03-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/7d2fcedf-aeb1-4f70-9552-95b0adf36ff7

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies